Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy.
about
The Influence of Immunization Route, Tissue Microenvironment, and Cytokine Cell Milieu on HIV-Specific CD8+ T Cells Measured Using Fluidigm Dynamic Arrays.Recombinant fowlpox virus vector-based vaccines: expression kinetics, dissemination and safety profile following intranasal delivery.Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose.Vaccination route can significantly alter the innate lymphoid cell subsets: a feedback between IL-13 and IFN-γ.
P2860
Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Novel HIV IL-4R antagonist vac ...... h greater protective efficacy.
@en
Novel HIV IL-4R antagonist vac ...... h greater protective efficacy.
@nl
type
label
Novel HIV IL-4R antagonist vac ...... h greater protective efficacy.
@en
Novel HIV IL-4R antagonist vac ...... h greater protective efficacy.
@nl
prefLabel
Novel HIV IL-4R antagonist vac ...... h greater protective efficacy.
@en
Novel HIV IL-4R antagonist vac ...... h greater protective efficacy.
@nl
P1433
P1476
Novel HIV IL-4R antagonist vac ...... th greater protective efficacy
@en
P2093
Charani Ranasinghe
Matthew Worley
P304
P356
10.1016/J.VACCINE.2014.08.023
P407
P577
2014-08-20T00:00:00Z